
    
      The study will include consecutive patients who agreed to participate in the study, which
      meet the criteria for inclusion, that is to say consecutive patients operated on by a
      bioprosthetic aortic valve replacement during the 3 months of inclusion. Patients will be
      included immediately after completion of aortic valve replacement.

      The data will be entered directly by the referent of each center, based on data from the
      French Society of Cardiology accessible by Internet on a secure site.

      The follow-up time will be 6 months

      The incidence of thromboembolic complications and bleeding and mortality within 6 months will
      be analyzed in a standardized manner according to the recommendations on the analysis of
      morbidity and mortality after valve surgery.
    
  